Business Context and Reporting Period
This Form 8-K Current Report was filed by iSpecimen Inc. (ISPC) on September 11, 2024. The filing reports on corporate governance actions taken to amend the Company's Certificate of Incorporation, specifically regarding a reverse stock split approved by stockholders at the Annual Meeting on July 19, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on capital structure adjustments.
Material Changes
- Reverse Stock Split Approval: The Board of Directors approved a one-for-twenty (1:20) reverse stock split on August 19, 2024, following stockholder authorization for a ratio between 1-for-10 and 1-for-20.
- Effective Date: The split is scheduled to become effective at 4:30 p.m. Eastern Time on September 13, 2024.
- Trading Resumption: Common stock will begin trading on a split-adjusted basis on September 16, 2024, on the Nasdaq Capital Market under the symbol "ISPC."
- Share Conversion: Every 20 shares of issued and outstanding common stock will be converted into one share. Fractional shares will be rounded up to the nearest whole share.
- Derivative Adjustments: Exercise prices and share counts for outstanding stock options, warrants, and restricted stock units will be proportionately adjusted. The number of shares reserved for issuance under stock incentive plans will also be reduced proportionately.
- Identification Changes: The new CUSIP number for the common stock will be 45032V207.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the procedural details of the stock split. The primary purpose is to disclose the material modification to the rights of security holders and the amendment to the Articles of Incorporation.
Investor Verification Checklist
- Verify the effective date of the reverse stock split (September 13, 2024) and the resumption of trading (September 16, 2024).
- Confirm the new CUSIP number (45032V207) for post-split trading.
- Review the impact of the 1:20 ratio on existing holdings, noting that fractional shares are rounded up.
- Check for adjustments to the exercise price and share count of any held stock options or warrants.
- Consult the Definitive Proxy Statement on Schedule 14A (filed June 10, 2024) for additional context on the proposal.